HomeStrategyA $435 Million Bet on ‘Reversing Aging’ Strategy A $435 Million Bet on ‘Reversing Aging’ Strategy June 7, 2026 0 213 FacebookXPinterestWhatsApp Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver. FacebookXPinterestWhatsApp Cody Previous articleDell sharpens data protection strategy as AI reshapes cyber resilienceNext articleLayoffs don’t have to feel inhumane RELATED ARTICLES Strategy Repetition Alone Doesn’t Make Motor Learning Last. These Research-Backed Signals From the Body May Help Strategy Your Search Engine Footprint Has Real Financial Value. Here’s What Most CEOs Miss. Strategy Trust in AI starts with human-AI boundaries Strategy AI Is Moving Faster Than Higher Education. Here’s Who Can Close the Gap. Must Read OpenAI chief scientist argues for AI research slowdown Tech Repetition Alone Doesn’t Make Motor Learning Last. These Research-Backed Signals From the Body May Help Strategy Hackers steal $320M in bitcoin from Liquid Network, return most of it after patch Tech Term Life Insurance Is Almost Always the Right Choice Over Whole Life Finance Hyperspectral satellite startup Pixxel nabs $100M investment Tech